PDK4 and Sepsis: This result suggests that imatinib might reduce the effect on PDC by downregulating PDK4 expression, thereby attenuating the inhibitory effect on PDC and oxidative response and improving oxygen supply in sepsis, consequently attenuating ALI in sepsis.